ELLEN

Ellenbarrie Industrial Gases Limited

Ellenbarrie Industrial Gases Limited (ELLEN) financial statements and selected valuation metrics through 30 June 2026.

Commodities›Chemicals›Chemicals & Petrochemicals›Industrial Gases

ellenbarrie.com

Ask AI

Key metrics

Price as of 2026-10-16

Stock price

₹339.05

Market cap

4,780 Cr

Stock P/E

39.6

P/B

4.89

ROE (FY26)

10.7%

ROCE (FY26)

12.5%

Operating margin (FY26)

27.7%

Debt / equity (FY26)

0.18

OCF / EBITDA (FY26)

114.1%

OCF / EBITDA (3Y)

62.8%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

Ellenbarrie Industrial Gases makes and supplies industrial gases in India, including oxygen, nitrogen, argon, carbon dioxide, acetylene, helium, hydrogen, medical oxygen and specialty gases, to customers in steel, pharmaceuticals, chemicals, defence and engineering.

Company snapshot

2ndBy market cap

Ranked among 4 companies in Industrial Gases.

What we see

Positives

✓Net margin of 30.6% — the business keeps a healthy share of every rupee it earns.

1 more signal from the filings.Sign in free to see them all

Statement tables · Standalone

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Standalone only

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

Metric	Jun 2025	Sept 2025	Dec 2025	Mar 2026	Jun 2026
Sales	84 Cr	89 Cr	81 Cr	87 Cr	99 Cr
Operating expenses (approx.)	53 Cr	56 Cr	56 Cr	60 Cr	61 Cr
EBITDA	31 Cr	33 Cr	25 Cr	27 Cr	38 Cr
OPM %	36.7%	37.5%	30.6%	31.1%	38.1%
Other income	7 Cr	13 Cr	16 Cr	15 Cr	17 Cr
Interest	5 Cr	1 Cr	1 Cr	2 Cr	2 Cr
Depreciation	5 Cr	5 Cr	5 Cr	6 Cr	6 Cr
Profit before tax	28 Cr	40 Cr	34 Cr	33 Cr	46 Cr
Tax %	32.8%	8.1%	23.8%	31.2%	24.7%
Net profit	19 Cr	37 Cr	26 Cr	23 Cr	35 Cr
EPS (₹)	₹1.42	₹2.61	₹1.85	₹1.62	₹2.48

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	205 Cr	269 Cr	312 Cr	342 Cr	Sign in free for the trailing twelve months
Operating expenses (approx.)	172 Cr	208 Cr	203 Cr	225 Cr	Sign in free for the trailing twelve months
EBITDA	34 Cr	62 Cr	110 Cr	116 Cr	Sign in free for the trailing twelve months
OPM %	16.4%	22.8%	35.1%	34.0%	Sign in free for the trailing twelve months
Other income	19 Cr	21 Cr	36 Cr	50 Cr	Sign in free for the trailing twelve months
Interest	4 Cr	8 Cr	17 Cr	9 Cr	Sign in free for the trailing twelve months
Depreciation	11 Cr	10 Cr	21 Cr	21 Cr	Sign in free for the trailing twelve months
Profit before tax	37 Cr	64 Cr	108 Cr	135 Cr	Sign in free for the trailing twelve months
Tax %	24.5%	29.5%	22.8%	22.8%	Sign in free for the trailing twelve months
Net profit	28 Cr	45 Cr	83 Cr	104 Cr	Sign in free for the trailing twelve months
EPS (₹)	₹2.15	₹3.46	₹6.36	₹7.54	Sign in free for the trailing twelve months
Dividend payout %	—	—	—	0.0%	Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity capital	7 Cr	7 Cr	26 Cr	28 Cr
Reserves	357 Cr	403 Cr	467 Cr	949 Cr
Borrowings	101 Cr	177 Cr	245 Cr	180 Cr
Other liabilities	87 Cr	86 Cr	107 Cr	142 Cr
Total liabilities	551 Cr	673 Cr	846 Cr	1,299 Cr
Fixed assets (net)	181 Cr	329 Cr	338 Cr	449 Cr
CWIP	71 Cr	0.42 Cr	45 Cr	78 Cr
Investments	111 Cr	170 Cr	194 Cr	401 Cr
Loans & advances	—	—	—	56 Cr
Inventories	8 Cr	11 Cr	14 Cr	14 Cr
Trade receivables	39 Cr	45 Cr	83 Cr	63 Cr
Cash & bank	11 Cr	0.92 Cr	0.18 Cr	1 Cr
Other assets	128 Cr	116 Cr	172 Cr	236 Cr
Total assets	551 Cr	673 Cr	846 Cr	1,299 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	39 Cr	44 Cr	4 Cr	133 Cr
Cash from investing	-114 Cr	-122 Cr	-57 Cr	-436 Cr
Cash from financing	87 Cr	67 Cr	52 Cr	305 Cr
Net cash flow	11 Cr	-10 Cr	-0.73 Cr	1 Cr
Free cash flow (OCF − Capex)	-56 Cr	-42 Cr	-65 Cr	-26 Cr

Ratios

Metric	Mar 2023	Mar 2024	Mar 2025	Mar 2026
ROCE %	8.8%	12.3%	16.9%	12.5%
ROE %	7.8%	11.0%	16.9%	10.7%
Debtor days	70	61	96	67
Inventory days	745	1050	1617	1337
Days payable	1560	1692	1601	1381
Cash conversion cycle	-745	-580	112	24
OCF / EBITDA %	115.4%	71.1%	3.9%	114.1%
OCF / EBITDA % (3 years)	—	—	42.4%	62.8%
Debt / equity	0.28	0.43	0.50	0.18
Current ratio	1.78	1.51	1.41	1.60
Net debt / EBITDA	2.67	2.86	2.23	1.54